Popular ozempic-like drugs may pose hidden risk during surgery, study investigates
NCT ID NCT07140289
Summary
This study aims to understand how diabetes and weight-loss medications called GLP-1 receptor agonists (like Ozempic or Wegovy) slow stomach emptying. Researchers want to determine if patients taking these drugs need to fast for a longer period before elective surgery to reduce the risk of stomach contents entering the lungs during anesthesia. The study will enroll 100 adults scheduled for surgery who are using these medications, using ultrasound to measure their stomach contents before their procedure.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTRIC EMPTYING are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Detroit Medical Center
Detroit, Michigan, 482001, United States
Conditions
Explore the condition pages connected to this study.